Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

There is an urgent and unmet need to develop effective therapies for triple negative breast cancers (TNBCs) which are much more aggressive and have poor prognosis due to lack of receptor targets for Her2-targeted and endocrine therapy. In this study we systematically evaluated the effect of Vorinost...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Theranostics
Auteurs principaux: Ma, Weina, Sun, Jingjing, Xu, Jieni, Luo, Zhangyi, Diao, Dingwei, Zhang, Ziqian, Oberly, Patrick J., Minnigh, Margaret Beth, Xie, Wen, Poloyac, Samuel M, Huang, Yi, Li, Song
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052901/
https://ncbi.nlm.nih.gov/pubmed/32194813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38973
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires